Exploring Third-Line Options in HER2+ mBC: Janet’s Case & Key Trial Insights from HER2CLIMB and EMILIA

Dr O’Shaughnessy leads a panel of medical experts in a discussion around a patient case surrounding findings from HER2CLIMB and EMILIA clinical trials.

EP: 1.Treatment Selection and Sequencing in Third Line Settings and Beyond

EP: 2.Understanding Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options

Now Viewing

EP: 3.Exploring Third-Line Options in HER2+ mBC: Janet’s Case & Key Trial Insights from HER2CLIMB and EMILIA

EP: 4.Treatment Sequencing in HER2+ mBC: Real-World Data & Key Considerations in Third-Line Treatment Selection

EP: 5.Managing Oral Treatments and Patient Support Strategies in HER2+ mBC: Multidisciplinary Perspectives

EP: 6.Barbara's Story: Navigating HER2+ MBC with Brain Metastases & Tucatinib-Based Treatment in the Second-Line Setting

EP: 7.Evolving Treatment Strategies in Early HER2+ Breast Cancer

EP: 8.Local and Systemic Approaches in Treating Brain Metastases in HER2+ mBC: The Role of Radiation and SRS

EP: 9.Treatment Selection, Sequencing, and Supportive Care for Brain Metastases in HER2+ mBC

Video content above is prompted by the following:

• Please explore key clinical trial data findings, emphasizing perspectives around clinical safety and efficacy.

Recent Videos